17 Jul More Data Needed To Justify Risks and Costs of IVC Filters
MedicalResearch.com Interview with:
Dr. Brown
David L. Brown, MD, FACC
Professor of Medicine
Cardiovascular Division
Washington University School of Medicine
St. Louis, MO 63110
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: There is very little high quality data for use of IVC filters in general and no high quality data for using them in the population of patients who have had a DVT or PE and have a contraindication to anticoagulation.
However, this is the patient population for which filters are most commonly placed. Using administrative, observational data, we found that IVC filter placement in this all-comer population was associated with an increased risk of 30-day mortality after adjusting for baseline differences and immortal time bias.
MedicalResearch.com: What should readers take away from your report?
Response: The main take-home message is that we need randomized trials of IVC filters in patients with a contraindication to anticoagulation and a DVT or PE. These devices come with significant risk and cost and we need better data to justify their use.
No disclosures
Citation:
[wysija_form id=”3″]
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on July 17, 2018 by Marie Benz MD FAAD